SEC Form 4 · accession 0001415889-19-000088
ACCELERON PHARMA INC · XLRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
CELGENE CORP
10% Owner
Period of report
Jan 18, 2019
Accepted (ET)
Jan 22, 2019 · 5:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001280600
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 18, 2019 | P | 706,206 | $43.00 | A | 6,824,685 | D |
Table II — derivative securities
No Table II lines on this filing.